Compare JJSF & RLAY Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
Current Price
Current Price
| Metric | JJSF | RLAY |
|---|---|---|
| Founded | 1971 | 2015 |
| Country | United States | United States |
| Employees | 4600 | N/A |
| Industry | Specialty Foods | Biotechnology: Biological Products (No Diagnostic Substances) |
| Sector | Consumer Staples | Health Care |
| Exchange | Nasdaq | Nasdaq |
| Market Cap | 1.5B | 1.3B |
| IPO Year | 1995 | 2020 |
| Metric | JJSF | RLAY |
|---|---|---|
| Price | $78.90 | $12.71 |
| Analyst Decision | Strong Buy | Strong Buy |
| Analyst Count | 2 | 7 |
| Target Price | ★ $140.00 | $16.86 |
| AVG Volume (30 Days) | 228.8K | ★ 2.6M |
| Earning Date | 05-05-2026 | 05-04-2026 |
| Dividend Yield | ★ 4.04% | N/A |
| EPS Growth | N/A | ★ 31.78 |
| EPS | ★ 0.05 | N/A |
| Revenue | ★ $1,022,038,000.00 | $15,355,000.00 |
| Revenue This Year | $0.43 | N/A |
| Revenue Next Year | $1.70 | $324.03 |
| P/E Ratio | $1,584.20 | ★ N/A |
| Revenue Growth | N/A | ★ 53.44 |
| 52 Week Low | $73.75 | $1.78 |
| 52 Week High | $142.69 | $13.04 |
| Indicator | JJSF | RLAY |
|---|---|---|
| Relative Strength Index (RSI) | 44.01 | 72.30 |
| Support Level | $73.75 | $9.16 |
| Resistance Level | $87.73 | N/A |
| Average True Range (ATR) | 2.59 | 0.73 |
| MACD | 0.44 | 0.13 |
| Stochastic Oscillator | 55.99 | 86.75 |
J&J Snack Foods Corp. manufactures snack foods and distributes frozen beverages, which it markets nationally to the foodservice and retail supermarket industries. The company's portfolio of frozen beverages, frozen novelties, and baked goods includes soft pretzels, frozen juice treats and desserts, stuffed sandwiches, churros, funnel cakes, cookies, and other snack foods and drinks. It operates through three segments: Food Service, which sells snacks, desserts, and baked goods at the point of sale; Retail Supermarkets, which sells frozen and prepackaged products to supermarkets; and Frozen Beverages, which sells frozen beverages under the ICEE, Slush Puppie, and Parrot Ice brands in the United States, Mexico, and Canada. The majority of revenue comes from the Food Service segment.
Relay Therapeutics Inc is a clinical-stage precision medicine company transforming the drug discovery process by combining leading-edge computational and experimental technologies with the goal of bringing life-changing therapies to patients. the Dynamo platform integrates an array of leading-edge computational and experimental approaches designed to drug-protein targets that have previously been intractable or inadequately addressed. The company is advancing a pipeline of medicine candidates to address targets in precision oncology and genetic disease, including product candidates, RLY-4008, RLY-2608, and GDC-1971 (formerly known as RLY-1971).